AstraZeneca slashing 1,200 jobs in Delaware, moving R&D to Gaithersburg

AstraZeneca said Monday it is eliminating 1,200 positions at its Wilmington, Del., offices, while moving research and development employees to Gaithersburg.

The Wilmington office will remain the pharmaceutical giant's North American headquarters.

MedImmune's Gaithersburg headquarters will gain 300 new jobs under the broader U.S. consolidation by parent company AstraZeneca PLC.

The changes are part of a global restructuring for AstraZeneca, which will have a new headquarters in Cambridge, England.

AstraZeneca…